Genmab — Oktober 2018
-
@Bulder I was basing myself a bit on this article we saw earlier this year, "Adoption of the More Rapid Infusion Protocol
A number of myeloma treatment centers in the United States are either using the new 90-minute Darzalex infusion protocol, or planning to do so in the near future" https://myelomabeacon.org/news/2018/04/30/shorter-darzalex-infusion-times/
-
Kenneth Anderson | ESH MM 2018 | Future combinations for the treatment of MM - http://www.multiplemyelomahub.com/medical-information/kenneth-anderson-esh-mm-2018-future-combinations-for-the-treatment-of-mm
-
ja, men sygeshusapotekerne betaler langt mindre end de listepriser du anfører
-
nej, de har ikke
opdateret endnu -
Genmab and Seattle Genetics Announce Tisotumab Vedotin Data to be Presented at ESMO 2018 Congress
-
-
God morgen.
-
God morgen
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind